Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fan-Fan Hou

Showing results (261-270 of 349) with videos related to

Pageof 35
Sort By:
Science Translational Medicine|April 16, 2025
Condensation of cellular prion protein promotes renal fibrosis through the TBK1-IRF3 signaling axisTantan Long, Yumei Lu, Yuanyuan Ma, et al.
Metabolism: Clinical and Experimental|August 3, 2024
Cannabinoid receptor 2 plays a key role in renal fibrosis through inhibiting lipid metabolism in renal tubular cellsShan Zhou, Xian Ling, Ye Liang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 15, 2023
Pentraxin 3 plays a key role in tubular cell senescence and renal fibrosis through inducing β-catenin signalingPei Luo, Haixia Zhang, Ye Liang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 12, 2016
Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive PatientsXianhui Qin, Youbao Li, Ningling Sun, et al.
Cell Death and Differentiation|June 17, 2022
B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-β-catenin pathwayJiemei Li, Jing Niu, Wenjian Min, et al.
The Lancet. Diabetes & Endocrinology|December 18, 2020
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trialDavid C Wheeler, Bergur V Stefánsson, Niels Jongs, et al.
The Lancet. Diabetes & Endocrinology|January 13, 2019
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J L Heerspink, Tom Greene, Hocine Tighiouart, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 29, 2019
Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugsXiao Huang, Junpei Li, Lishun Liu, et al.
Diabetes|December 18, 2019
Erratum. Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature. Diabetes 2019;68Ivan Hernandez-Diaz, Jiaqi Pan, Carlo Alberto Ricciardi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2017
Impact of achieved blood pressure on renal function decline and first stroke in hypertensive patients with chronic kidney diseaseYoubao Li, Min Liang, Chongfei Jiang, et al.
Pageof 35

Showing results (261-270 of 349) with videos related to

Sort By:
Pageof 35
Science Translational Medicine|April 16, 2025
Condensation of cellular prion protein promotes renal fibrosis through the TBK1-IRF3 signaling axisTantan Long, Yumei Lu, Yuanyuan Ma, et al.
Metabolism: Clinical and Experimental|August 3, 2024
Cannabinoid receptor 2 plays a key role in renal fibrosis through inhibiting lipid metabolism in renal tubular cellsShan Zhou, Xian Ling, Ye Liang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 15, 2023
Pentraxin 3 plays a key role in tubular cell senescence and renal fibrosis through inducing β-catenin signalingPei Luo, Haixia Zhang, Ye Liang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 12, 2016
Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive PatientsXianhui Qin, Youbao Li, Ningling Sun, et al.
Cell Death and Differentiation|June 17, 2022
B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-β-catenin pathwayJiemei Li, Jing Niu, Wenjian Min, et al.
The Lancet. Diabetes & Endocrinology|December 18, 2020
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trialDavid C Wheeler, Bergur V Stefánsson, Niels Jongs, et al.
The Lancet. Diabetes & Endocrinology|January 13, 2019
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J L Heerspink, Tom Greene, Hocine Tighiouart, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 29, 2019
Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugsXiao Huang, Junpei Li, Lishun Liu, et al.
Diabetes|December 18, 2019
Erratum. Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature. Diabetes 2019;68Ivan Hernandez-Diaz, Jiaqi Pan, Carlo Alberto Ricciardi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2017
Impact of achieved blood pressure on renal function decline and first stroke in hypertensive patients with chronic kidney diseaseYoubao Li, Min Liang, Chongfei Jiang, et al.
Pageof 35